MyBiotech has deep expertise in developing both oral and parenteral dosage forms from early feasibility studies to formulation optimization and clinical manufacturing.
Our teams work across small molecules, biologics, and complex APIs to create stable, scalable, and high-performance drug products tailored to your delivery route.
Our services with scalability in mind—combining feasibility studies, formulation screening, analytical development and characterization. Whether your goal is improved solubility, controlled release, enhanced bioavailability, or stable injectables, MyBiotech provides end-to-end CDMO support including:
Our integrated approach reduces development timelines and ensures consistent, scalable results from early R&D to clinical supply.
We develop injectable controlled release formulations with a strong focus on stability, usability, and controlled delivery. Our capabilities include: • Long-acting injectables (LAI) for sustained therapeutic effect • Low-volume SC/IM formulations suitable for patient-friendly administration • Stability optimization for sensitive APIs, biologics, and nanoparticles • Targeted drug delivery using nano- and micro-structured carriers • Inorganic nanoparticle carriers for specialized therapeutic applications These parenteral solutions are optimized for sterile manufacturing, high API loading, and precise particle-size control.
For oral delivery, we engineer formulations that overcome solubility, stability, and bioavailability challenges while ensuring patient compliance. Key capabilities include: • Enhanced bioavailability through nanoparticle engineering and solubility improvement • No fed/fasted variability, improving pharmacokinetic predictability • Taste-masking strategies for improved patient acceptance • Enhanced chemical and physical stability • Targeted, sustained, and extended-release formulations for optimized therapeutic profiles Our technologies support both conventional and nanoparticle-based oral dosage forms.
For APIs in solution, we assemble nanoparticles directly at the molecular level. This enables: • High API loading • Highly customizable nanocarrier architectures • Consistent particle formation with excellent batch homogeneity • Easily scalable
Starting with bulk drug crystals, our top-down technology reduces particle size with exceptional precision. This approach ensures: • Narrow, uniform particle-size distributions • Improved dissolution and bioavailability • Enable filter-sterilization • Reliable scalability towards sterile, oral, or topical dosage forms
Our proprietary, fully scalable platform is optimized and standardized for pharmaceutical applications and delivers:
With MyBiotech, you gain a development partner who combines scientific depth with the speed and flexibility required in dynamic nanomedicine development ecosystem. MyBiotech integrates R&D, scale-up, analytical development, stability testing, and GMP manufacturing including aseptic fill-and-finish—all under one roof.
MyBiotech’s proprietary production platform is fully scalable and supports both top-down and bottom-up nanoparticle engineering.
It enables high API concentrations, precise particle-size adjustment, and highly uniform particle-size distributions for a wide range of nanomedicine applications. Whether producing nanosuspensions via top-down micronization or creating complex nanostructures through bottom-up assembly, our technology delivers consistent, high-quality results.
Nanoprecipitation / flash precipitation - Micronization and controlled particle-size reduction - W/O and W/O/W emulsification processes - Scalable microreactor-based continuous manufacturing
Highly controlled, continuous processes ensure excellent repeatability - Robust control of critical process parameters (CPPs) - Reliable manufacturing suitable for preclinical, clinical, and GMP scale
Particle size precisely controlled through process parameter tuning - Achievable PDI < 0.1, supporting high uniformity - Flexible size ranges for parenteral, oral, and topical applications
Stay informed, connect with our experts, and discover how MyBiotech advances nanomedicine through trusted technologies and GMP manufacturing solutions.
